AXIM Biotechnologies Inc (AXIM)
0.01
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
AXIM Biotechnologies Total Liabilities (Quarterly): 11.78M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.78M |
| September 30, 2023 | 9.999M |
| June 30, 2023 | 14.00M |
| March 31, 2023 | 10.20M |
| December 31, 2022 | 9.037M |
| September 30, 2022 | 8.859M |
| June 30, 2022 | 8.254M |
| March 31, 2022 | 8.488M |
| December 31, 2021 | 7.662M |
| September 30, 2021 | 9.600M |
| June 30, 2021 | 9.315M |
| March 31, 2021 | 9.64M |
| December 31, 2020 | 9.749M |
| September 30, 2020 | 9.841M |
| June 30, 2020 | 10.07M |
| March 31, 2020 | 11.28M |
| December 31, 2019 | 8.452M |
| September 30, 2019 | 8.554M |
| June 30, 2019 | 9.043M |
| March 31, 2019 | 8.305M |
| December 31, 2018 | 8.171M |
| September 30, 2018 | 6.994M |
| June 30, 2018 | 7.654M |
| March 31, 2018 | 8.652M |
| December 31, 2017 | 8.477M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.174M |
| June 30, 2017 | 7.842M |
| March 31, 2017 | 3.720M |
| December 31, 2016 | 3.821M |
| September 30, 2016 | 4.468M |
| June 30, 2016 | 3.298M |
| March 31, 2016 | 3.234M |
| December 31, 2015 | 2.957M |
| September 30, 2015 | 2.588M |
| June 30, 2015 | 2.261M |
| March 31, 2015 | 1.287M |
| December 31, 2014 | 1.319M |
| September 30, 2014 | 1.251M |
| June 30, 2014 | 0.055M |
| March 31, 2014 | 0.0575M |
| December 31, 2013 | 0.1507M |
| September 30, 2013 | 0.1419M |
| June 30, 2013 | 0.1366M |
| March 31, 2013 | 0.1361M |
| December 31, 2012 | 0.1375M |
| September 30, 2012 | 0.0561M |
| June 30, 2012 | 0.0488M |
| March 31, 2012 | 0.0774M |
| December 31, 2011 | 0.1271M |
| September 30, 2011 | 0.0041M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.662M
Minimum
Dec 2021
14.00M
Maximum
Jun 2023
9.675M
Average
9.600M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.122M |
| Shareholders Equity (Quarterly) | -7.657M |
| Debt to Equity Ratio | -0.7396 |
| Current Ratio | 0.0262 |
| Net Debt Paydown Yield | -0.37% |